{"id":"NCT02629965","sponsor":"Boehringer Ingelheim","briefTitle":"Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients","officialTitle":"A Randomised, Double-blinded, Active-controlled 2-way Cross Over Trial to Assess the Effects of 6 Weeks Treatment of Once Daily Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Delivered by RESPIMAT Inhaler Compared With Tiotropium Delivered by RESPIMAT Inhaler on Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02-12","primaryCompletion":"2017-03-24","completion":"2017-04-17","firstPosted":"2015-12-15","resultsPosted":"2019-06-06","lastUpdate":"2019-06-06"},"enrollment":184,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]}],"arms":[{"label":"tiotropium + olodaterol","type":"EXPERIMENTAL"},{"label":"tiotropium","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multi-centre, randomised, double-blinded, active-controlled, 2-way cross over trial to assess the effects of once daily administration of orally inhaled tiotropium + olodaterol FDC or tiotropium (both delivered by the RESPIMAT Inhaler) on pulmonary function (lung hyperinflation), exercise capacity (6-minute walk distance) and physical activities after 6 weeks of treatment in Japanese patients with Chronic Obstructive Pulmonary Disease.","primaryOutcome":{"measure":"Inspiratory Capacity at Rest Measured at 60 Minutes Post-dose","timeFrame":"Day 43, 60 minutes post-dose after 6 weeks of each treatment","effectByArm":[{"arm":"Tiotropium 5 μg","deltaMin":1.875,"sd":0.019},{"arm":"Tiotropium + Olodaterol 5/5 μg","deltaMin":1.99,"sd":0.019}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":4},"locations":{"siteCount":43,"countries":["Japan"]},"refs":{"pmids":["31496678"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":182},"commonTop":["Viral upper respiratory tract infection"]}}